MC1R and metastatic melanoma: [225Ac]Ac–crown–αMSH was developed containing a chelator with a tetraazacrown-6 backbone with four pendant acetate side arms, which is connected to a peptide to target the melanocortin 1 receptor (MC1R) in specifically expressed primary and metastatic melanoma [40].